Westwood Holdings Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $916K | Sell |
1,186
-298
| -20% | -$228K | 0.01% | 356 |
|
|
2025
Q4 | $1.15M | Sell |
1,484
-174
| -10% | -$118K | 0.01% | 367 |
|
|
2025
Q3 | $932K | Sell |
1,658
-11,898
| -88% | -$6.73M | 0.01% | 383 |
|
|
2025
Q2 | $7.12M | Buy |
13,556
+1,974
| +17% | +$1.1M | 0.05% | 243 |
|
|
2025
Q1 | $7.35M | Sell |
11,582
-442
| -4% | -$304K | 0.06% | 233 |
|
|
2024
Q4 | $8.57M | Sell |
12,024
-90
| -0.7% | -$75.5K | 0.07% | 231 |
|
|
2024
Q3 | $12.7M | Sell |
12,114
-187
| -2% | -$208K | 0.05% | 243 |
|
|
2024
Q2 | $12.9M | Sell |
12,301
-202
| -2% | -$196K | 0.06% | 226 |
|
|
2024
Q1 | $12M | Sell |
12,503
-266
| -2% | -$253K | 0.09% | 199 |
|
|
2023
Q4 | $11.2M | Sell |
12,769
-180
| -1% | -$148K | 0.09% | 194 |
|
|
2023
Q3 | $10.7M | Sell |
12,949
-982
| -7% | -$772K | 0.1% | 182 |
|
|
2023
Q2 | $10M | Sell |
13,931
-310
| -2% | -$239K | 0.09% | 199 |
|
|
2023
Q1 | $11.7M | Sell |
14,241
-1,483,601
| -99% | -$1.12B | 0.11% | 196 |
|
|
2022
Q4 | $67.6M | Buy |
1,497,842
+1,480,215
| +8,397% | +$1.09B | 0.6% | 63 |
|
|
2022
Q3 | $12.1M | Sell |
17,627
-1,965
| -10% | -$1.24M | 0.14% | 157 |
|
|
2022
Q2 | $11.6M | Sell |
19,592
-2,041
| -9% | -$1.33M | 0.13% | 177 |
|
|
2022
Q1 | $15.1M | Sell |
21,633
-69
| -0.3% | -$43.7K | 0.14% | 167 |
|
|
2021
Q4 | $13.7M | Buy |
21,702
+1,093
| +5% | +$672K | 0.12% | 175 |
|
|
2021
Q3 | $12.5M | Sell |
20,609
-140
| -0.7% | -$86.9K | 0.14% | 178 |
|
|
2021
Q2 | $11.6M | Sell |
20,749
-6,936
| -25% | -$3.51M | 0.12% | 188 |
|
|
2021
Q1 | $13.1M | Buy |
27,685
+3,331
| +14% | +$1.62M | 0.13% | 193 |
|
|
2020
Q4 | $11.8M | Buy |
24,354
+306
| +1% | +$165K | 0.14% | 187 |
|
|
2020
Q3 | $13.5M | Sell |
24,048
-91
| -0.4% | -$55.2K | 0.17% | 178 |
|
|
2020
Q2 | $15.1M | Buy |
24,139
+7,490
| +45% | +$4.25M | 0.2% | 160 |
|
|
2020
Q1 | $8.13M | Buy |
16,649
+9,533
| +134% | +$3.93M | 0.12% | 198 |
|
|
2019
Q4 | $2.67M | Sell |
7,116
-103
| -1% | -$34.7K | 0.03% | 292 |
|
|
2019
Q3 | $2M | Buy |
7,219
+682
| +10% | +$202K | 0.02% | 301 |
|
|
2019
Q2 | $2.05M | Sell |
6,537
-776
| -11% | -$258K | 0.02% | 309 |
|
|
2019
Q1 | $3M | Buy |
7,313
+2,374
| +48% | +$978K | 0.03% | 241 |
|
|
2018
Q4 | $1.84M | Sell |
4,939
-2,622
| -35% | -$960K | 0.02% | 260 |
|
|
2018
Q3 | $3.06M | Sell |
7,561
-1,342
| -15% | -$511K | 0.03% | 249 |
|
|
2018
Q2 | $3.07M | Buy |
8,903
+1,979
| +29% | +$619K | 0.03% | 251 |
|
|
2018
Q1 | $2.38M | Buy |
+6,924
| New | +$2.41M | 0.02% | 277 |
|
Other funds holding REGN
VCM
N
Westwood Holdings Group's REGN Position: Q1 2026 in Review
Westwood Holdings Group reduced its Regeneron Pharmaceuticals (REGN) stake by 20% in Q1 2026, selling an estimated $228K and leaving 1,186 shares worth $916K. The position accounts for 0.01% of the portfolio, ranked #356.
Westwood Holdings Group first reported a position in REGN in Q1 2018 and has held it in 33 quarters since. The position peaked at $67.6M in Q4 2022. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Westwood Holdings Group held 1,186 shares of Regeneron Pharmaceuticals worth $916K as of Q1 2026.
- Westwood Holdings Group sold 298 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $228K.
- Regeneron Pharmaceuticals made up 0.01% of Westwood Holdings Group's portfolio in Q1 2026, its #356 holding.
- Westwood Holdings Group first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 33 quarters since.
- Westwood Holdings Group's Regeneron Pharmaceuticals position peaked at $67.6M in Q4 2022.
- 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Westwood Holdings Group's 13F filing for Q1 2026, filed 15 May 2026.